Suppr超能文献

2 型糖尿病患者的部分和全口洁治和根面平整:临床参数及细胞因子和破骨细胞生成相关因子水平的 12 个月随访。

Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors.

机构信息

Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, São Paulo, Brazil.

出版信息

J Periodontal Res. 2012 Feb;47(1):45-54. doi: 10.1111/j.1600-0765.2011.01403.x. Epub 2011 Aug 2.

Abstract

BACKGROUND AND OBJECTIVE

The aim of this study was to evaluate the effects of full-mouth scaling and root planing (FMSRP) and partial-mouth scaling and root planing (PMSRP), up to 12 mo after treatment, on clinical parameters, and levels of cytokines and osteoclastogenesis-related factors in type 2 diabetic subjects with chronic periodontitis.

MATERIAL AND METHODS

Thirty-four subjects received FMSRP (n = 17) or PMSRP (n = 17) within 24 h or in multiple sessions, respectively. Clinical parameters and local levels of tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), interleukin (IL)-17, IL-23, IL-4, receptor activator of NF-β ligand and osteoprotegerin were assessed at baseline, and 3, 6 and 12 mo after therapies.

RESULTS

Clinical parameters improved after both therapies (p < 0.05), and no between-group differences were observed at any time-point (p > 0.05). Overall, there were no considerable differences in the local levels of the biomarkers studied between groups (p > 0.05). The IL-23 concentration and total amount of IFN-γ increased in the FMSRP group and decreased in the PMSRP group from baseline to 3 mo and from baseline to 6 mo, respectively (p < 0.05).

CONCLUSION

Both PMSRP and FMSRP promoted benefits in clinical parameters and showed a similar modulation of cytokines and osteoclastogenesis-related factors at 12 mo in type 2 diabetic subjects.

摘要

背景与目的

本研究旨在评估全口牙周洁治和根面平整(FMSRP)与部分牙周洁治和根面平整(PMSRP)治疗后 12 个月对 2 型糖尿病伴慢性牙周炎患者临床参数以及细胞因子和破骨细胞生成相关因子水平的影响。

材料与方法

34 例患者在 24 小时内或多次就诊时分别接受 FMSRP(n=17)或 PMSRP(n=17)治疗。在治疗前、治疗后 3、6 和 12 个月时,评估临床参数和局部肿瘤坏死因子-α(TNF-α)、干扰素-γ(IFN-γ)、白细胞介素(IL)-17、IL-23、IL-4、核因子-κB 受体激活剂和骨保护素的水平。

结果

两种治疗方法均可改善临床参数(p<0.05),且各时间点两组间无差异(p>0.05)。总体而言,两组间研究生物标志物的局部水平无显著差异(p>0.05)。FMSRP 组的 IL-23 浓度和 IFN-γ总量从基线到 3 个月以及从基线到 6 个月分别增加,而 PMSRP 组则减少(p<0.05)。

结论

PMSRP 和 FMSRP 均可促进 2 型糖尿病患者的临床参数改善,并且在 12 个月时对细胞因子和破骨细胞生成相关因子具有相似的调节作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验